A study on breast cancer cells suggested that E2 is an anti-apoptotic agent whose response is mediated by non-genomic cytoplasmic signal networks that converge on BAD, in turn regulating changes in the mitochondrial membrane potential (43). This evidence concerns the gene BAD and breast carcinoma.